Clinical Trials Browser

Phase 2 × Glioma × durvalumab × Clear all

NCT03991832 2024-07-18

SOLID

Phase 2 Recruiting

CNSGastrointestinal

Glioma, Cholangiocarcinoma

NCT02794883 2022-04-18

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 13 charts

Glioblastoma, Glioma